|
|
|
|
|
 |
| |
Charles V. Clevenger, MD, PhD. 
Diana, Princess of Wales Professor of Cancer Research Leader, Breast Cancer Program
Robert H. Lurie Comprehensive Cancer Center
Professor of Pathology
Northwestern University
website: http://www.pathology.northwestern.edu/Faculty/FacultyBio.cfm?ID=86
|
|
|
|
|
| |
Topic:
|
|
"Prolactin and Breast Cancer" |
|
| |
|
|
|
|
| |
When:
|
|
Monday, December 1, 2008
12:00PM – 1:00PM
|
|
| |
Location:
|
|
Ward Conference Room 3-015 |
|
| |
|
|
| |
Selected Recent References for Charles V. Clevenger, MD, PhD.
Zheng J, JE Koblinski J, Dutson LV, Feeney YB, Clevenger CV. Peptidyl-prolyl isomerase regulation of Jak2 and the progression of human breast cancer. Cancer Res, Oct 1;68(19):7769-78.
Clevenger CV, Zheng J, Jablonski L, Galbaugh T, Feng F. From bench to bedside: Future potential for translation of prolactin inhibitors for the treatment of human breast cancer. J Mammary Gland Biol Neoplasia,13:147-156, 2008.
McHale K, Tomaszewski JE Puthiyaveettil R, LiVolsi VA, Clevenger CV. Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma. Mod Pathol, 21:565-571, 2008.
Miller SL Antico G, Raghunath PN, Tomaszewski JE, Clevenger CV. Nek3 kinase regulates prolactin-mediated cytoskeletal reorganization and motility of breast cancer cells. Oncogene, 26:4668-4678, 2007.
Gadd SL, Clevenger CV. Ligand-independent dimerization of the human prolactin receptor isoforms: Functional implications. Mol Endocrinol. 20:2734-2746, 2006.Apr;88(4):342-53. Epub 2008 Feb 18.
 View more Publications by Charles V. Charles V. Clevenger, MD, PhD.,
listed in the National Library of Medicine (PubMed) |
|
|
|
|
|
|
